Literature DB >> 27753285

HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population.

C M Mariaselvam1,2, C Fortier3, D Charron2,3, R Krishnamoorthy2, R Tamouza2,3, V S Negi4.   

Abstract

Rheumatoid arthritis (RA) is a complex multifactorial autoimmune disease characterized by inflammatory arthritis. The precise etiology and pathogenesis of RA remains elusive but evidence points towards stochastic interactions between genetic and environmental factors. This study investigated the distribution of human leucocyte antigen (HLA)-DRB1/DQB1 alleles in South Indian patients with rheumatoid arthritis (RA) and their influence on RA susceptibility and clinical phenotype. Low resolution HLA-DRB1 and -DQB1 typing was performed in 271 RA patients and 233 healthy controls by polymerase chain reaction (PCR) using sequence-specific primers (SSP). HLA-DRB1*10 was found to be more frequent in patients (Pc = 0.004, OR = 2.23, 95% CI = 1.5-3.34) than controls. This difference persisted in RF positive (Pc = 9 × 10-6 , OR = 2.45, 95% CI = 1.62-3.74), ACPA positive (Pc = 0.007, OR = 2.10, 95% CI = 1.35-3.29), ACPA negative (Pc = 0.001, OR = 2.45, 95% CI = 1.50-3.97) and both RF and ACPA positive subgroup of patients (Pc = 0.003, OR = 2.22, 95% CI = 1.41-3.51). On the contrary, the HLA-DRB1*13 (Pc = 0.01, OR = 0.43, 95% CI = 0.25-0.73) and HLA-DRB1*14 (Pc = 0.003, OR = 0.43, 95% CI = 0.26-0.69) alleles were over-represented in controls than patients. Further, distribution of the prominent Caucasian RA risk allele DRB1*04 did not differ between patients and controls in our study population. We did not find any association between DQB1 alleles and RA susceptibility or autoantibody status. The haplotypes DQB1*05-DRB1*10 (P = 6.8 × 10-6 , OR = 2.46, 95% CI = 1.63-3.79) and DQB1*06-DRB1*15 (P = 0.03, OR = 1.41, 95% CI = 1.02-1.96) were more frequent in patients while DQB1*05-DRB1*14 (P = 8.4 × 10-4 , OR = 0.44, 95% CI = 0.26-0.74) and DQB1*06-DRB1*13 (P = 9.5 × 10-4 , OR = 0.40, 95% CI = 0.21-0.72) were higher in controls. To conclude, HLA-DRB1*10 is associated with RA while HLA-DRB1*13 and HLA-DRB1*14 alleles confer protection in south Indian Tamils.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA-DR/DQ polymorphism; autoantibodies; clinical phenotype; protection; rheumatoid arthritis; susceptibility

Mesh:

Substances:

Year:  2016        PMID: 27753285     DOI: 10.1111/tan.12910

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  3 in total

1.  Promising targets and drugs in rheumatoid arthritis: a module-based and cumulatively scoring approach.

Authors:  Xingyan Li; Yejing Yang; Guili Sun; Wanwu Dai; Xuri Jie; Yongjun Du; Runjie Huang; Jiaming Zhang
Journal:  Bone Joint Res       Date:  2020-08-02       Impact factor: 5.853

2.  Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.

Authors:  Sai Kumar Dunga; Chengappa Kavadichanda; Latika Gupta; R Naveen; Vikas Agarwal; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2021-05-29       Impact factor: 2.631

3.  The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study.

Authors:  Lay Kim Tan; Chun Lai Too; Lina Marcela Diaz-Gallo; Sulaiman Wahinuddin; Ing Soo Lau; Hussein Heselynn; Shahril Nor-Shuhaila; Suk Chyn Gun; Mageswaran Eashwary; Mohamed Said Mohd-Shahrir; Mohd Mokhtar Ainon; Rosman Azmillah; Othman Muhaini; Murad Shahnaz; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Journal:  Arthritis Res Ther       Date:  2021-01-30       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.